BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11912107)

  • 21. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
    Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
    Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
    Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
    J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
    Molz S; Tharine DC; Decker H; Tasca CI
    Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
    Chen WF; Sung CS; Jean YH; Su TM; Wang HC; Ho JT; Huang SY; Lin CS; Wen ZH
    Neuroscience; 2010 Feb; 165(4):1217-32. PubMed ID: 19932886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.
    Hua XY; Svensson CI; Matsui T; Fitzsimmons B; Yaksh TL; Webb M
    Eur J Neurosci; 2005 Nov; 22(10):2431-40. PubMed ID: 16307586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mitochondrial dysfunction on glutamate receptor-mediated neurotoxicity in cultured rat spinal motor neurons.
    Kanki R; Nakamizo T; Yamashita H; Kihara T; Sawada H; Uemura K; Kawamata J; Shibasaki H; Akaike A; Shimohama S
    Brain Res; 2004 Jul; 1015(1-2):73-81. PubMed ID: 15223368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged minocycline treatment impairs motor neuronal survival and glial function in organotypic rat spinal cord cultures.
    Pinkernelle J; Fansa H; Ebmeyer U; Keilhoff G
    PLoS One; 2013; 8(8):e73422. PubMed ID: 23967343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate enhances DNA fragmentation in cultured spinal motor neurons of rat.
    Manabe Y; Wang JM; Warita H; Shiro Y; Kashihara K; Abe K
    Neurol Res; 2001 Jan; 23(1):79-82. PubMed ID: 11210436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis.
    Cid C; Alvarez-Cermeño JC; Regidor I; Salinas M; Alcazar A
    J Neurol Sci; 2003 Jan; 206(1):91-5. PubMed ID: 12480091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
    Rothstein JD; Bristol LA; Hosler B; Brown RH; Kuncl RW
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4155-9. PubMed ID: 7910402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain.
    Inta I; Vogt MA; Vogel AS; Bettendorf M; Gass P; Inta D
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):673-7. PubMed ID: 26482736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration.
    De Paola M; Mariani A; Bigini P; Peviani M; Ferrara G; Molteni M; Gemma S; Veglianese P; Castellaneta V; Boldrin V; Rossetti C; Chiabrando C; Forloni G; Mennini T; Fanelli R
    Mol Med; 2012 Sep; 18(1):971-81. PubMed ID: 22562723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mode of spinal motor neurons degeneration in a model of slow glutamate excitotoxicity in vitro.
    Matyja E; Nagańska E; Taraszewska A; Rafałowska J
    Folia Neuropathol; 2005; 43(1):7-13. PubMed ID: 15827885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation.
    Weber M; Eisen A; Stewart HG; Andersen PM
    Brain; 2000 Jul; 123 ( Pt 7)():1505-15. PubMed ID: 10869061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftriaxone-mediated upregulation of the glutamate transporter GLT-1 contrasts neurotoxicity evoked by kainate in rat organotypic spinal cord cultures.
    Bajrektarevic D; Nistri A
    Neurotoxicology; 2017 May; 60():34-41. PubMed ID: 28257918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDP-choline protects motor neurons against apoptotic changes in a model of chronic glutamate excitotoxicity in vitro.
    Matyja E; Taraszewska A; Nagańska E; Grieb P; Rafałowska J
    Folia Neuropathol; 2008; 46(2):139-48. PubMed ID: 18587708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective vulnerability of spinal cord motor neurons to non-NMDA toxicity.
    Saroff D; Delfs J; Kuznetsov D; Geula C
    Neuroreport; 2000 Apr; 11(5):1117-21. PubMed ID: 10790892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death.
    D'Antoni S; Berretta A; Seminara G; Longone P; Giuffrida-Stella AM; Battaglia G; Sortino MA; Nicoletti F; Catania MV
    Neurobiol Dis; 2011 Jun; 42(3):252-64. PubMed ID: 21232601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical study of the distribution of the free radical scavenging enzymes Cu/Zn superoxide dismutase (SOD1); MN superoxide dismutase (MN SOD) and catalase in the normal human spinal cord and in motor neuron disease.
    Shaw PJ; Chinnery RM; Thagesen H; Borthwick GM; Ince PG
    J Neurol Sci; 1997 Apr; 147(2):115-25. PubMed ID: 9106116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.